Mahmoud A. Al-Sha’er*, Qosay A. Al-Balas and Mohammad A. Hassan Pages 1 - 18 ( 18 )
Aims: Discovery of new Glo-I inhibitors as potential anticancer agents
Background: Glyoxalase system is ubiquitous system in human cells which has been examined thoroughly for its role in cancerous diseases. It performs detoxifying endogenous harmful metabolites, mainly methylglyoxal (MG) into non-toxic bystanders
Objective: Structure based model Hypo(2ZA0_2_02) combined with 3D-QSAR modeling were applied to predict glyoxalase I inhibition and to explain their activity.
Method: Currently, high throughput screening approach was used to investigate the activity of inhouse database composed of 205 compounds.
Result: 15 compounds were found active as glyoxalase I inhibitors. The 15 candidates showed more than 50% inhibition with low micromolar IC50 ranges between 5.0 to 42.0 μM.
Conclusion: They have been successfully mapped and fitted the Hypo(2ZA0_2_02) model which explain the presence of anti-glyoxalase I activity.
Other: This model could be used in future for further development of new and novel glyoxylase I inhibitors.
Human glyoxalase-I, metalloenzyme, Anticancer, Zinc-binding groups.
Faculty of Pharmacy, Zarqa University, Zarqa 13132, Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid